New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
06:18 EDTUTHRUnited Therapeutics announces Japan approval for Remodulin
United Therapeutics announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin Injection for the treatment of pulmonary arterial hypertension, or PAH, by subcutaneous and intravenous administration. Remodulin will be sold in Japan under the brand name Treprost by Mochida Pharmaceutical, under an exclusive distribution agreement with United Therapeutics.
News For UTHR From The Last 14 Days
Check below for free stories on UTHR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
06:07 EDTUTHRUnited Therapeutics reports Q2 EPS $2.30, consensus $1.75
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use